Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An extremely rare, WHO grade I, circumscribed and slow-growing tumor that arises from the neurohypophysis or infundibulum and described in adults. It is characterized by the presence of elongated, spindle-shaped neoplastic glial cells that form storiform patterns or interlacing fascicular arrangements. Signs and symptoms include visual disturbances, headache, amenorrhea, and decreased libido.
Biomarker and diagnostic research for pituicytoma has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pituicytoma.
21 publications have been identified in PubMed for pituicytoma. Research spans Case Report / Case Series (48%), Review / Meta-Analysis (19%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 48% |
Data assembled from 3 of 12 sources · Last updated Sep 17, 2026, 10:22 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
4 |
19% |
Clinical study results | 3 | 14% |
Testing and diagnosis research | 2 | 10% |
Disease patterns and progression | 1 | 5% |
New treatment approaches | 1 | 5% |
Fernández SC (2026). [PMID: 42006272](https://pubmed.ncbi.nlm.nih.gov/42006272/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Sah RK (2026). [PMID: 41497147](https://pubmed.ncbi.nlm.nih.gov/41497147/). *Annals of medicine and surgery (2012)*. [Case Report / Case Series]
Wu J (2025). [PMID: 40226090](https://pubmed.ncbi.nlm.nih.gov/40226090/). *JCEM case reports*. [Case Report / Case Series]
Alcântara T (2025). [PMID: 40206592](https://pubmed.ncbi.nlm.nih.gov/40206592/). *Brain & spine*. [Case Report / Case Series]
Ghosal K (2025). [PMID: 40329838](https://pubmed.ncbi.nlm.nih.gov/40329838/). *Clinical neuropathology*. [Case Report / Case Series]
Teltayev D (2025). [PMID: 41256330](https://pubmed.ncbi.nlm.nih.gov/41256330/). *Frontiers in oncology*. [Case Report / Case Series]
Li J (2025). [PMID: 40171196](https://pubmed.ncbi.nlm.nih.gov/40171196/). *Frontiers in endocrinology*. [Clinical Trial Publication]
Kremenevski N (2025). [PMID: 40186832](https://pubmed.ncbi.nlm.nih.gov/40186832/). *Pituitary*. [Diagnostic / Biomarker]
Lamback E (2025). [PMID: 40175820](https://pubmed.ncbi.nlm.nih.gov/40175820/). *Endocrine*. [Case Report / Case Series]
Pala A (2025). [PMID: 40805263](https://pubmed.ncbi.nlm.nih.gov/40805263/). *Cancers*. [Review / Meta-Analysis]